National and Kapodistrian University of Athens
Η σπινθηρογραφική συμβολή στην αυτόλογη μεταμόσχευση κυττάρων μυελού των οστών σε ασθενείς με παλαιό μη βιώσιμο πρόσθιο έμφραγμα του μυοκαρδίου
Abstract
dc:descriptionThe aim of this study was to examine the adherence of selected progenitor bone marrow stem cells to the infarcted myocardium, after intracoronary infusion, as well as to evaluate the therapeutic outcome, by means of scintigraphic methods, in patients with an old, non- viable anterior myocardial infarction. Eighteen (16 male, 2 female) patients underwent intracoronary administration of selected CD133+ and CD 133-CD34+ progenitor cells. One hour after intracoronary injection, planar and tomographic Tc-99m-HMPAO images were acquired in 13 patients (11 male, 2 female). The 1 h uptake of radiolabelled cells was calculated in 9 patients and the 24 h uptake, in 4 patients. Rest re-injection Tl-201 studies were performed in the 18 patient treatment group, before treatment (baseline studies), as well as during mid-term (5.9±2.85 months) and long-term (10.8±3.9 months) follow up. We quantitatively analyzed the effectiveness of the treatment, in the seven segments, which correspond to the LAD territory, using the left ventricular segmentation model (17 segments) and calculating the perfusion ratio. Perfusion ratio is defined as the count per pixel ratio of the defective area, divided by the normal one. A 12 patient (11 male, 1 female) control group was follow up on medical therapy. Twelve patients of the treatment group (11 male, 1 female) underwent I-123-MIBG SPECT studies, before treatment, as well as during long-term follow up. The number of progenitor stem cells administrated via the intracoronary route was 1.7•107±0.5•107 cells. The mean value of labeling efficiency was 23,5±4,6%. The viability of labeled cells was greater than 95%. Coronary angiographies and scintigraphic images were well correlated. The 1h uptake ranged from 7.01 to 12.8%, with a mean value of 9.5±2.45%. The 24 h uptake ranged from 4.7 to 9% with a mean value of 6.8±2.32%. Comparison of Tl-201 tomographic images with the respective Tc-99m-HMPAO ones, revealed an intense accumulation of stem cells in the infarcted area. Apart from the anterior wall and the apex of the left ventricular of myocardium, significant distribution of the labeled cells was observed in liver and spleen in 1h whole body Tc-99m-HMPAO images. A high bladder and intestine uptake was observed in 24 h whole body images. The perfusion was considerably improved in all segments (p<0.01) except segment 8, which corresponds to mid anterior septal wall of left ventricular (p=0.058). The increase of perfusion ratios ranged from 6.2% (basal anterior wall) to 20.1% (apex). Perfusion ratios were not significantly changed in the 12 patient control group. The I-123-MIBG SPECT studies, revealed a statistically significant increase of ratios (p<0.01), in all 7 segments of LAD territory. This increase ranged from 5.7% (apical anterior septal wall) to 14.2% (apical anterior wall). The above results show that the autologous transplantation of the selected bone marrow stem cell population, improves the perfusion as well as the sympathetic innervation, in patients suffering by an old, non-viable anterior myocardial infarction. Therapeutic effects of stem cell therapy can be reliably measured by Nuclear Medicine methods.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kollaros, Nikolaos
- Κολλάρος, Νικόλαος
Subjects
dc:subject × 22- Κύτταρα μυελού των οστών
- Καρδιακή αποκατάσταση
- Ενδοστεφανιαία χορήγηση κυττάρων μυελού των οστών
- Σπινθηρογράφημα αιμάτωσης μυοκαρδίου
- Σπινθηρογράφημα μυοκαρδίου με I-123-MIBG
- Θεραπεία εμφράγματος με μεταμόσχευση κυττάρων
- Κυτταρική θεραπεία
- Καρδιακή ανεπάρκεια
- Bone marrow cells
- Cardiac repair
- Intracoronary administration of bone marrow cells
- Myocardial perfusion scintigraphy
- I-123-MIBG myocardial scintigraphy
- Myocardial infarction treatment with cell transplantation
- Cell therapy
- Heart failure
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Clinical Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25982